Form 8-K - Current report:
SEC Accession No. 0001193125-25-122485
Filing Date
2025-05-19
Accepted
2025-05-19 16:31:28
Documents
12
Period of Report
2025-05-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d932010d8k.htm   iXBRL 8-K 43575
  Complete submission text file 0001193125-25-122485.txt   161048

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20250514.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20250514_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20250514_pre.xml EX-101.PRE 11269
14 EXTRACTED XBRL INSTANCE DOCUMENT d932010d8k_htm.xml XML 3626
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 25964493
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)